Marex Group’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
Marex Group's NAMS Position: Q3 2026 in Review
Marex Group opened a new position in NewAmsterdam Pharma (NAMS) in Q3 2026: 12,000 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #1384 among its holdings.
183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- Marex Group held 12,000 shares of NewAmsterdam Pharma worth $292K as of Q3 2026.
- NewAmsterdam Pharma was a new Marex Group position in Q3 2026.
- NewAmsterdam Pharma made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1384 holding.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.